HMS LINCS ID:
|
50028
|
Name:
|
LNZTA3WT4
|
Alternative Names:
|
LNZTA3p53WT4; WT4
|
LINCS ID:
|
LCL-1345
|
Alternative ID:
|
CLO_0007371
|
Parent Cell Line:
|
|
Reference Source:
|
ATCC CRL-11543
|
Organism:
|
Homo sapiens
|
Organ:
|
brain
|
Tissue:
|
|
Cell Type:
|
|
Details of Cell Type:
|
|
Donor Sex:
|
unknown
|
Donor Age:
|
|
Donor Ethnicity:
|
|
Donor Health Status:
|
|
Disease:
|
DOID:3068, glioblastoma
|
Details of Disease:
|
|
Production Details:
|
|
Genetic Modification(s):
|
none
|
Known Mutations:
|
|
Citation Information for Mutations:
|
COSS1240170
|
Verification Reference Profile:
|
DNA Profile (STR, source: ATCC):
Amelogenin: X,Y
CSF1PO: 11,12
D13S317: 11
D16S539: 9,12
D5S818: 12
D7S820: 10,12
THO1: 9.3
TPOX: 8,9
vWA: 15,17
|
Growth Properties:
|
adherent
|
Recommended Culture Conditions:
|
From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose supplemented with 1 microgram/ml tetracycline, 90%; heat-inactivated fetal bovine serum, 10%.
Subculturing: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:10 is recommended
|
Relevant Citations:
|
|
Usage Note:
|
|
Comments:
|
|
Date Publicly Available:
|
2012-04-25
|
Most Recent Update:
|
2016-04-04
|